Acetylcholine
|
Basic information |
| Metabolite name | Acetylcholine |
 | HMDB0000895 |
 |
C01996 |
 |
187 |
| Synonyms | NA |
| No. of studies | 19 |
|
Basic information |
| Metabolite name | Acetylcholine |
| HMDB0000895 |
|
C01996 |
|
187 |
| Synonyms | NA |
| No. of studies | 19 |
|
Relationship between Acetylcholine and depression (count: 19) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1022 | Type1 | CUS group vs. control group | Faece | C57BL/6 mouse | Up |
| Study M1022 | Type2 | CUS + Tongxieyaofang neutral polysaccharide + Tongxieyaofang acidic polysaccharide group vs. CUS group | Faece | C57BL/6 mouse | Down |
| Study M1022 | Type2 | CUS + middle dose of Tongxieyaofang neutral polysaccharide group vs. CUS group | Faece | C57BL/6 mouse | Down |
| Study M1090 | Type1 | CUMS group vs. control group | Plasma | BALb/c mouse | Down |
| Study M1126 | Type1 | ovariectomy group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M1126 | Type2 | ovariectomy + high dose of Danggui-Shaoyao-San group vs. ovariectomy group | Hippocampus | Sprague-Dawley rat | Up |
| Study M1126 | Type2 | ovariectomy + low dose of Danggui-Shaoyao-San group vs. ovariectomy group | Hippocampus | Sprague-Dawley rat | Up |
| Study M1126 | Type2 | ovariectomy + middle dose of Danggui-Shaoyao-San group vs. ovariectomy group | Hippocampus | Sprague-Dawley rat | Up |
| Study M1135 | Type2 | PSD + electroacupuncture group vs. PSD group | Faece | Sprague-Dawley rat | Up |
| Study M199 | Type1 | FSL group vs. FRL group | Frontal cortex | Sprague-Dawley rat | Up |
| Study M199 | Type1 | FSL group vs. FRL group | Hippocampus | Sprague-Dawley rat | Down |
| Study M523 | Type1 | CUMS group vs. control group | Brain | Wistar rat | Down |
| Study M540 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M563 | Type1 | CUMS group vs. control group | Brain | Sprague-Dawley rat | Down |
| Study M563 | Type2 | CUMS + TCM group vs. CUMS group | Brain | Sprague-Dawley rat | Up |
| Study M570 | Type1 | CMS group vs. control group | Hippocampus | BALB/c mouse | Down |
| Study M570 | Type1 | CMS group vs. control group | Serum | BALB/c mouse | Down |
| Study M581 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M581 | Type1 | CUMS group vs. control group | Hypothalamus | Sprague-Dawley rat | Down |
| Study M581 | Type2 | CUMS + fluoxetine group vs. CUMS group | Prefrontal cortex | Sprague-Dawley rat | Up |
| Study M581 | Type2 | CUMS + fluoxetine group vs. CUMS group | Hypothalamus | Sprague-Dawley rat | Up |
| Study M767 | Type1 | CUMS group vs. control group | Cortex | C57BL/6 mouse | Up |
| Study M767 | Type1 | CUMS group vs. control group | Striatum | C57BL/6 mouse | Up |
| Study M767 | Type1 | CUMS group vs. control group | Hippocampus | C57BL/6 mouse | Up |
| Study M767 | Type1 | CUMS group vs. control group | Amygdala | C57BL/6 mouse | Up |
| Study M767 | Type2 | CUMS + HLJDD group vs. CUMS group | Hippocampus | C57BL/6 mouse | Down |
| Study M767 | Type2 | CUMS + HLJDD group vs. CUMS group | Amygdala | C57BL/6 mouse | Down |
| Study M820 | Type3 | multiple-dose nefazodone group vs. multiple-dose control group | Brain | ICR mouse | Up |
| Study M839 | Type1 | MDD group vs. control group | Plasma | Human | Down |
| Study M840 | Type1 | A1/A2 beta-casein group vs. control group | Frontal cortex | Wistar rat | Up |
| Study M911 | Type1 | CUS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M916 | Type1 | CUMS group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Up |
| Study M928 | Type1 | CUMS group vs. control group | Faece | C57BL/6 mouse | Down |
| Study M942 | Type1 | CUMS group vs. control group | Prefrontal cortex | C57BL/6 mouse | Up |
| Study M942 | Type1 | CUMS group vs. control group | Amygdala | C57BL/6 mouse | Up |
| Study M942 | Type1 | CUMS group vs. control group | Hippocampus | C57BL/6 mouse | Up |
| Study M942 | Type1 | CUMS group vs. control group | Striatum | C57BL/6 mouse | Up |
| Study M942 | Type2 | CUMS + berberine group vs. CUMS group | Striatum | C57BL/6 mouse | Down |
| Study M942 | Type2 | CUMS + berberine group vs. CUMS group | Hippocampus | C57BL/6 mouse | Down |
| Study M957 | Type1 | CSDS group vs. control group | Hippocampus | C57BL/6 J mouse | Up |
| Study M957 | Type1 | CSDS group vs. control group | Serum | C57BL/6 J mouse | Up |